A genetic test is being used to determine the proper dosage of the blood thinner warfarin in patients at the University of Illinois Hospital & Health Sciences System. The medical center is one of the first in the nation to use genetic information in order to cater to individual patients’ specific dosages of a drug that ranks among the leading causes of drug-related adverse events. Warfarin is an anticoagulant that has been on the market for more than 50 years. It is used to treat deep vein thrombosis and pulmonary embolism and to prevent stroke in patients with atrial fibrillation ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.